Media Update: Sanofi and Regeneron provide update on Dupixent® (dupilumab) sBLA for Chronic Spontaneous Urticaria

https://ift.tt/SXuAEK5

from Sanofi - Aventis Groupe https://ift.tt/xFJciLb
via IFTTT

Post a Comment

0 Comments